Issue
Alert me when new journal issues are available via or via
Editorial Board page IFC Full-Text PDF (44 KB)
Tumour Review
Quality of systematic reviews in pediatric oncology – A systematic review, 19 October 2009 Andreas Lundh, Sebastiaan L. Knijnenburg, Anders W. Jørgensen, Elvira C. van Dalen, Leontien C.M. Kremer pages 645-652 Abstract | Full Text | Full-Text PDF (253 KB) | Add-Ons
Anti-Tumour Treatment
Clinical applications of rituximab in allogeneic stem cell transplantation: Anti-tumor and immunomodulatory effects, 17 August 2009 Voravit Ratanatharathorn, Steven Pavletic, Joseph P. Uberti pages 653-661 Abstract | Full Text | Full-Text PDF (324 KB)
The role of topoisomerase IIα and HER-2 in predicting sensitivity to anthracyclines in breast cancer patients, 16 September 2009 Catherine Oakman, Erica Moretti, Francesca Galardi, Libero Santarpia, Angelo Di Leo pages 662-667 Abstract | Full Text | Full-Text PDF (234 KB)
Integration of neoadjuvant and adjuvant chemotherapy in patients with resectable liver metastases from colorectal cancer, 07 September 2009 Mohamed Hebbar, François-René Pruvot, Olivier Romano, Jean-Pierre Triboulet, Aimery de Gramont pages 668-675 Abstract | Full Text | Full-Text PDF (196 KB)
Second-line therapy for advanced pancreatic cancer: A review of the literature and future directions, 16 September 2009 Ana Custodio, Javier Puente, Javier Sastre, Eduardo Díaz-Rubio pages 676-684 Abstract | Full Text | Full-Text PDF (203 KB)
New Drugs
Irreversible pan-ErbB tyrosine kinase inhibitors and breast cancer: Current status and future directions, 07 September 2009 Alberto Ocaña, Eitan Amir pages 685-691 Abstract | Full Text | Full-Text PDF (434 KB)
Clinical pharmacokinetics of tyrosine kinase inhibitors, 07 September 2009 Nielka P. van Erp, Hans Gelderblom, Henk-Jan Guchelaar pages 692-706 Abstract | Full Text | Full-Text PDF (380 KB)
V-ATPase inhibitors and implication in cancer treatment, 16 September 2009 Mario Pérez-Sayáns, José Manuel Somoza-Martín, Francisco Barros-Angueira, José Manuel Gándara Rey, Abel García-García pages 707-713 Abstract | Full Text | Full-Text PDF (385 KB)
High-grade glioma mouse models and their applicability for preclinical testing, 22 September 2009 Nienke A. de Vries, Jos H. Beijnen, Olaf van Tellingen pages 714-723 Abstract | Full Text | Full-Text PDF (337 KB)
Complications of Treatment
Dysphagia in head and neck cancer, 14 September 2009 Kapila Manikantan, Shailesh Khode, Suhail I. Sayed, Justin Roe, Chris M. Nutting, Peter Rhys-Evans, Kevin J. Harrington, Rehan Kazi pages 724-732 Abstract | Full Text | Full-Text PDF (232 KB)
General and Supportive Care
Quality of life in patients with metastatic renal cell carcinoma: The importance of patient-reported outcomes, 25 August 2009 David Cella pages 733-737 Abstract | Full Text | Full-Text PDF (415 KB)
Update on the use of erythropoiesis-stimulating agents (ESAs) for the management of anemia of multiple myeloma and lymphoma, 04 September 2009 Eirini Katodritou, Meletios A. Dimopoulos, Konstantinos Zervas, Evangelos Terpos pages 738-743 Abstract | Full Text | Full-Text PDF (170 KB)
Making sense of post-treatment surveillance in head and neck cancer: when and what of follow-up, 10 September 2009 Kapila Manikantan, Shailesh Khode, Raghav C. Dwivedi, Rajan Palav, Chris M. Nutting, Peter Rhys-Evans, Kevin J. Harrington, Rehan Kazi pages 744-753 Abstract | Full Text | Full-Text PDF (336 KB)
Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: A review of current guidelines, 17 September 2009 Lars J. Petersen pages 754-764 Abstract | Full Text | Full-Text PDF (226 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
